Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin

被引:115
作者
Kihara, F [1 ]
Arima, H [1 ]
Tsutsumi, T [1 ]
Hirayama, F [1 ]
Uekama, K [1 ]
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 8620973, Japan
关键词
D O I
10.1021/bc025557d
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To improve gene transfer activity of a new nonviral vector, a polyamidoamine dendrimer (G2) conjugate with (x-cyclodextrin (alpha-CDE conjugate (G2)), we prepared alpha-CDE conjugates with dendrimer having different generations (G3 and G4), and their gene transfer activities were compared with those of alpha-CDE conjugate (G2) and TransFast, a novel transfection reagent. a-CDE conjugates (G2, G3, and G4) formed the complexes with pDNA, changing the zeta-potential and particle size of pDNA complexes and the protection of pDNA from DNase I in a charge ratio-dependent manner, although their differences at higher charge ratios (vector/pDNA) were small. The gene transfer activity of a-CDE conjugates (G2, G3, and G4) was higher than that of the corresponding dendrimer alone in NIH3T3 and RAW264.7 cells. Of these CDE conjugates, alpha-CDE conjugate (G3) had a superior gene transfer activity which was comparable to that of TransFast in NIH3T3 cells. The intracellular distribution of pDNA after application of the pDNA complex with alpha-CDE conjugate (G3) to NIH3T3 cells was different from that with dendrimer alone (G3), although the cellular association of pDNA was almost comparable among all vectors. alpha-CDE conjugate (G3) strongly interacted with a fluorescence probe, 2-(p-toluidinyl)naphthalene-6-sulfonate (TNS), suggesting that the conjugate possesses the inclusion ability with biomembrane constituents such as phospholipids after transfection. These results suggest that a-CDE conjugates, particularly the G3 conjugate, could be novel nonviral gene transfer agents.
引用
收藏
页码:1211 / 1219
页数:9
相关论文
共 41 条
[1]   Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence [J].
Abdou, S ;
Collomb, J ;
Sallas, F ;
Marsura, A ;
Finance, C .
ARCHIVES OF VIROLOGY, 1997, 142 (08) :1585-1602
[2]   Cyclodextrin derivatives in pharmaceutics [J].
Albers, E ;
Muller, BW .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1995, 12 (04) :311-337
[3]   Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins [J].
Arima, H ;
Kihara, F ;
Hirayama, F ;
Uekama, K .
BIOCONJUGATE CHEMISTRY, 2001, 12 (04) :476-484
[4]   SERUM ALKALINE DNASE ACTIVITY IN NORMAL OR NONHOSPITALIZED INDIVIDUALS [J].
AVALLLUNDQVIST, E ;
ECONOMIDOUKARAOGLOU, A ;
SJOVALL, K ;
LANS, M ;
TAPER, HS ;
ROBERFROID, M ;
ENEROTH, P .
CLINICA CHIMICA ACTA, 1989, 185 (01) :35-43
[5]  
Bender M.L., 1978, Cyclodextrin Chemistry
[6]   Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers [J].
Bielinska, A ;
KukowskaLatallo, JF ;
Johnson, J ;
Tomalia, DA ;
Baker, JR .
NUCLEIC ACIDS RESEARCH, 1996, 24 (11) :2176-2182
[7]   Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine [J].
Croyle, MA ;
Roessler, BJ ;
Hsu, CP ;
Sun, R ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1348-1355
[8]   Vehicles for oligonucleotide delivery to tumours [J].
Dass, CR .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (01) :3-27
[9]   Cationic polymer based gene delivery systems [J].
De Smedt, SC ;
Demeester, J ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :113-126
[10]  
EICHMAN JD, 2000, PHARM SCI TECHNOL TO, V3, P32